Repositório Institucional da Produção Científica da Marinha do Brasil (RI-MB)

Por favor, use este identificador para citar o enlazar este ítem: https://www.repositorio.mar.mil.br/handle/ripcmb/844519
Título : LQB‑118 compound inhibits migration and induces cell death in glioblastoma cells
Autor : Bernardo, Paula Sabbo
Guimarães, Gustavo Henrique C.
Faria, Fernanda Costa C. de
Longo, Gabriel M. da Cunha
Lopes, Giselle Pinto de Faria
Daher Netto, Chaquip
Costa, Paulo R. R.
Maia, Raquel C.
Palabras clave : Saúde
Tumores Cerebrais
Fecha de publicación : 2020
Editorial : Demetrios Spandidos
Resumen : Glioblastoma (GBM) is the most frequent malignant brain tumor. It represents the most aggressive astrocytoma with an overall survival of 14 months. Despite improvements in surgery techniques, radio‑ and chemotherapy, most patients present treatment resistance, recurrence and disease progression. Therefore, development of effective alternative therapies is essential to overcome treatment failure. The purpose of the study was to evaluate the antitumoral activity of the synthetic compound LQB‑118, in vitro. Monolayer and three‑dimensional (3D) cell culture systems of human‑derived GBM cell lines were used to evaluate the effect of LQB‑118 on cell viability, cell death and migration. LQB‑118 reduced cell viability as determined by MTT and trypan blue exclusion assays and promoted apoptosis in monolayer cell lines with an intrinsic temozolomide (TMZ)‑resistance profile. In 3D culture models, LQB‑118 reduced cell viability as evaluated by APH assay and inhibited cell migration while the TMZ resistance profile was maintained. Moreover, LQB‑118 reduced p38 and AKT expression and phosphorylation, whereas it reduced only the phosphorylated ERK1/2 form. LQB‑118 reduced p38 and NRF2 expression, an axis that is associated with TMZ resistance, revealing a mechanism to overcome resistance. LQB‑118 also demonstrated an additional effect when combined with ionizing radiation and cisplatin. In conclusion, the present data demonstrated that LQB‑118 maintained its effectiveness in a 3D cell conformation, which shares more similarities with the tumor mass. LQB‑118 is a promising agent for GBM treatment as monotherapy and associated with radiotherapy or cisplatin. Its effect is associated with inhibition of GBM‑related survival signaling pathways.
Access: Acceso abierto
URI : http://www.repositorio.mar.mil.br/handle/ripcmb/844519
Type: Artículo
Aparece en las colecciones: Saúde: Coleção de Artigos

Ficheros en este ítem:
No hay ficheros asociados a este ítem.

Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.